Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

NEO - NEOGENOMICS INC

IEX Last Trade
16.79
-0.020   -0.119%

Share volume: 14,331
Last Updated: Fri 27 Dec 2024 08:30:04 PM CET

PREVIOUS CLOSE
CHG
CHG%
$16.81
-0.02
-0.12%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
4.54%
1 Month
-2.59%
3 Months
19.17%
6 Months
29.54%
1 Year
-15.71%
2 Year
90.10%
Key data
Stock price
$16.79
P/E Ratio 
-26.95
DAY RANGE
$16.72 - $17.32
EPS 
-$0.62
52 WEEK RANGE
$13.16 - $19.00
52 WEEK CHANGE
$6.80
MARKET CAP 
2.117 B
YIELD 
N/A
SHARES OUTSTANDING 
128.158 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/04/2024
BETA 
1.62
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,023,316
AVERAGE 30 VOLUME 
$727,331
Company detail
CEO: Christopher M. Smith
Region: US
Website: neogenomics.com
Employees: 2,100
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited.

Recent news